Orgenesis Stock Price on July 9, 2021
| ORGS Stock | USD 0.51 0.01 2.00% |
If you're considering investing in Orgenesis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orgenesis stands at 0.51, as last reported on the 19th of April, with the highest price reaching 0.51 and the lowest price hitting 0.50 during the day. Orgenesis is abnormally volatile given 3 months investment horizon. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. We were able to analyze and collect data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.31% are justified by taking the suggested risk. Use Orgenesis Semi Deviation of 9.1, risk adjusted performance of 0.085, and Coefficient Of Variation of 817.59 to evaluate company specific risk that cannot be diversified away.
Orgenesis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Orgenesis |
Sharpe Ratio = 0.1223
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ORGS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.71 actual daily | 94 94% of assets are less volatile |
Expected Return
| 1.31 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Orgenesis is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orgenesis by adding it to a well-diversified portfolio.
Orgenesis Valuation on July 9, 2021
It is possible to determine the worth of Orgenesis on a given historical date. On July 9, 2021 Orgenesis was worth 3.3 at the beginning of the trading date compared to the closed value of 3.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orgenesis stock. Still, in general, we apply an absolute valuation method to find Orgenesis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orgenesis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orgenesis' related companies.
| Open | High | Low | Close | Volume | |
04/04/2022 | 3.30 | 3.49 | 3.20 | 3.35 | 82,400 |
| 3.35 | 4.04 | 3.30 | 3.69 | 144,400 |
| Backtest Orgenesis | | | Orgenesis History | | | Orgenesis Valuation | Next |
Orgenesis Trading Date Momentum on July 9, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Orgenesis Fundamentals Correlations and Trends
By evaluating Orgenesis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orgenesis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orgenesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Orgenesis Stock history
Orgenesis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orgenesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orgenesis will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orgenesis stock prices may prove useful in developing a viable investing in Orgenesis
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.
Orgenesis Stock Technical Analysis
Orgenesis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Orgenesis Period Price Range
Low | April 4, 2022
| High |
3.30 | 3.35 |
Orgenesis April 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Orgenesis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orgenesis shares will generate the highest return on investment. By undertsting and applying Orgenesis stock market strength indicators, traders can identify Orgenesis entry and exit signals to maximize returns
Orgenesis Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Orgenesis' price direction in advance. Along with the technical and fundamental analysis of Orgenesis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orgenesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.085 | |||
| Jensen Alpha | 1.32 | |||
| Total Risk Alpha | 0.2847 | |||
| Sortino Ratio | 0.0929 | |||
| Treynor Ratio | (4.42) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Orgenesis Stock analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Orgenesis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orgenesis. If investors know Orgenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orgenesis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Orgenesis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.